Regulation of mesangial cell proliferation

Kidney International

Volumn 56, Issue 4, 1999, Pages 1199-1207

  Schöcklmann, Harald O ^a   Lang, Stefan ^a   Bernd Sterzel, R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Glomerulosclerosis; Hyperplasia; Inflammation; Injury; Lesions; Tumorigenesis

Indexed keywords

CYCLIN D1; CYCLINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CELL CYCLE; CELL DEATH; CELL HYPERPLASIA; CELL PROLIFERATION; CONFERENCE PAPER; DNA REPAIR; EXTRACELLULAR MATRIX; GLOMERULOPATHY; GLOMERULOSCLEROSIS; KIDNEY INJURY; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032861063     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00710.x     Document Type: Conference Paper

References (65)

1. PABST R, STERZEL RB: Cell renewal of glomerular cell types in normal rats: An autoradiographic analysis. Kidney Int 24:626-631, 1983
2. PESCE CM, STRIKER LJ, PETEN E, ELLIOT SJ, STRIKER GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605, 1991
3. FLOEGE J, BURNS MW, ALPERS CE, YOSIII.MURA A, PRITZL P, GORDON K, SEIFERT RA, BOWEN-POPE DF, COUSER \VG, JOHNSON RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297309, 1992
4. MACK,\Y K, STRIKER LJ, PINKERT CA, BRINSTER RL, STRIKER GE: Glomerulosclerosis and renal cysts in mice transeenic for the early region of SV40. Kidney Int 32:827-837, 1987
5. FLOEGE J, ENG E, YOUNG BA, COUSER WG, JOHNSON RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380, 1993
6. FUKUI M, NAKAMURA T, EBIHARA I, NAGAOKA I, TOMINO Y, KOIDE H: Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular sclerosis. J Lab Clin Med 121:224-234,1993
7. JOHNSON RJ, RAINES E\V, FLOEGE J, YOSHIMURA A, PRITZL P, ALPERS C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
8. PIPPIN JW, Qu Q, MELIER L, SIIANKLAND SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclindependent kinase antagonist. J Clin Invest 100:2512-2520, 1997
9. BACCHUS WM, HOEDEMAEKER PJ, ROZING J, BAKKER WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies: A sequential histological and ultrastructural study in the rat. Lab Invest 55:680-687, 1986
10. CATTELL V, BRADFIELD JW: Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom: A morphologic study. Am J Pathol 87:511-524, 1977
11. HARRISON DJ: Cell death in the diseased glomerulus. Histopatltology 12:679-683, 19S8
12. BAKER AJ.MOONEY A, HUGHES J.LoMBARDiD, JOHNSON RJ,SAVILL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
13. SHIMIZU A, KITAMURA H, MASUDA Y, ISIIIZAKI M, SUGISAKI Y, YAMANAKA N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
14. SUGIYAMA H, KASHIIIARA N, MAKING H, YAMASAKI Y, OTA A: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
15. SHERR CJ: d-type cyclins. Trends Biocliein Sci 20:187-190, 1995
16. FUNK JO, GALLOWAY DA: Inhibiting CDK inhibitors: New lessons from DNA tumor viruses. Trends Biochem Sci 23:337-341, 1998
17. SIIANKLAND SJ: Cell-cycle control and renal disease. Kidney Int 52:294-308, 1997
18. TERADA Y, INOSHITA S, NAKASIIIMA O, KUWAHARA M, SASAKI S, MARUMO F: Cyclins and the cyclin-kinase system-their potential roles in nephrology. Nephrol Dial Transplant 13:1913-1916, 1998
19. DYSON N: The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262, 199S
20. SHANKLAND SJ, HUGO C, COATS SR, NANGAKU M, PICHLER RH, GORDON KL, PIPPIN J, ROBERTS JM, COUSER WO, JOHNSON RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Inl 50:1230-1239, 1996
21. LABAERJ, GARRETT MD, STEVENSON LF, SLINGERLANDJM, SANDIIU C, CHOU HS, FATTAEY A, HARLOW E: New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862, 1997
22. LANG S, HARTNER A, STERZEL RB, SCIIOECKLMANN HO: Requirement of cyclin Dl in mesangial cell mitogenesis. (submitted for publication)
23. MICHIELI P, CHEDID M, LIN D, PIERCE JH, MERCER WE, GIVOL D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395, 1994
24. DATTO MB, Li Y, PANUS JF, HOWE DJ, XIONG Y, WANG XF: Transforming growth factor ßinduces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Nail Acad Sci USA 92:5545-5549, 1995
25. TERADA Y, YAMADA T, NAKASHIMA O, TAMAMORI M, ITO H, SASAKI S, MARUMO F: Overexpression of cell cycle inhibitors (p!6INK4 and p21Cipl) and cyclin Dl using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 8:51-60, 1997
26. HOFER G, GRIMMER C, SUKHATME VP, STERZEL RB, RUPPRECIIT HD: Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Cliem 271:28306-28310, 1996
27. MAESHIMA Y, KASIIIHARA N, SUGIYAMA H, MAKING H, OTA Z: Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation. J Am Soc Nephrol 7:2219-2229, 1996
28. TERADA Y, INOSHITA S, NAKASIIIMA O, YAMADA T, TAMAMORI M, ITO H, SASAKI S, MARUMO F: Cyclin Dl, p!6, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells. Kidney hit 53:76-83, 1998
29. TOMITA N, HORIUCIII M, TOMITA S, GIBBONS GH, KIM JY, BARAN D, DZAU VJ: An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am J Physiol 275:F278-F284, 1998
30. MAESHIMA Y, KASHIHARA N, YASUDA T, SUGIYAMA H, SEKIKAWA T, OKAMOTO K, KANAO K, WATANABE Y, KANWAR YS, MAKINO H: Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest 101:2589-2597, 1998
31. SCIIOECKLMANN HO, RUPPRECHT HD, STERZEL RB: Mesangial cell growth control in glomerular inflammation. Proc R Coll Pliys Edinb 26:352-373, 1996
32. SHANKLAND SJ, JOHNSON RJ: TGF-ß in glomerular disease. Miner Electrolyte Metab 24:168-173, 1998
33. MACKAY K, STRIKER LJ, STAUFFER JW, Doi T, AGODOA LY, STRIKER GE: Transforming growth factor-ß: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:11601167, 1989
34. BORDER WA, OKUDA S, LANGUINO LR, RUOSLAHTI E: Transforming growth factor-ß regulates production of proteoglycans by mesangial cells. Kidney lut 37:689-695, 1990
35. SCIIOECKLMANN HO, RUPPRECHT HD, ZAUNER I, STERZEL RB:TGFßl-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Kidney Int 51:1228-1236, 1997
36. KITAMURA M, BURTON S, ENGLISH J, KAWACIII H, FINE LG: Transfer of a mutated gene encoding active transforming growth factor-ßl suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 48:1747-1757, 1995
37. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor ßl. Nature 346:371-374, 1990
38. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCIII Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of trans-
39. forming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
40. ISAKA Y, FUJIWARA Y, UEDA N, KANEDA Y, KAMADA T, IMAI E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J din Invest 92:2597-2601, 1993
41. GRANA X, GARRIGA J, MAYOL X: Role of the retinoblastoma protein family, pRB, p!07 and p!30 in the negative control of cell growth. Oncogene 17:3365-3383, 1998
42. FRANCH HA, SHAY JW, ALPERN RJ, PREISIG PA: Involvement of pRB family in TGFβ-dependent epithelial cell hypertrophy. J Cell Biol 129:245-254, 1995
43. STEPIIENSON LA, HANEY LB, HUSSAINI IM, KARNS LR, GLASS WF: Regulation of smooth muscle α-actin expression and hypertrophy in cultured mesangial cells. Kidney Int 54:1175-1187, 1998
44. CHOI ME, KIM EG, HUANG Q, BALLERMANN BJ: Rat mesangial cell hypertrophy in response to transforming growth factor-βl. Kidney Int 44:948-958, 1993
45. WOLF G, SIIARMA K, CIIEN Y, ERICKSEN M, ZIYADEH FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
46. WOLF G, SCIIROEDER R, ZIYADEH FN, THAISS F, ZAHNER G, STAHL RA: High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Physiol 273:F348-F356, 1997
47. Kip1 in diabetic db/db mouse: Role of hyperglycemia. Kidney Int 53:869-879, 1998
48. SIMONSON MS, GULP LA, DüNN MJ: Rat mesangial cell-matrix interactions in culture. Exp Cell Res 184:484-498, 1989
49. MARINIDES GN, SUCHARD SJ, MOOKERJEE BK: Role of thrombospondin in mesangial cell growth: Possible existence of an autocrine feedback growth circuit. Kidney Int 46:350-357, 1994
50. CAENAZZO C, GARBISA S, CEOL M, BAGGIO B, BORSATTI A, MARCHI E, GAMBARO G: Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: Molecular clues for its activity in nephropathy. Nephrol Dial Transplant 10:175-184, 1995
51. GROGGEL GC, MARINIDES GN, HOVINGH P, HAMMOND E, LINKER A: Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol 258:F259-F265, 1990
52. MORITA H, SlIlNZATO T, DAVID G, MlZUTANI A; HABUCHI H, FUJITA Y, ITO M, ASAI J, MAEDA K, KIMATA K: Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis. Lab Invest 71:528-535, 1994
53. ZHU X, OHTSUBO M, BOHMER RM, ROBERTS JM, ASSOIAN RK: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 133:391-403, 1996
54. FANG F, OREND G, WATANABE N, HUNTER T, RUOSLAIITI E: Dependence of cyclin E-cdk2 kinase activity on cell anchorage. Science 271:499-502, 1996
55. MEREDITH J JR, TAKADA Y, FORNARO M, LANGUINO LR, SCHWARTZ MA: Inhibition of cell cycle progression by the alternatively spliced integrin βlC. Science 269:1570-1572, 1996
56. FORNARO M, MANZOTTI M, TALLINI G, SLEAR AE, BOSARI S, RuosLAHTI E, LANGUINO LR: βlC integrin in epithelial cells correlates with a nonproliferative phenotype: Forced expression of β1C inhibits prostate epithelial cell proliferation. Ami Palhol 153:1079-1087, 1998
57. FORNARO M, TALLINI G, ZHENG DQ, FLANAGAN WM, MANZOTTI M, LANGUINO LR: p27 (kipl) acts as a downstream effector of and is coexpressed with the βlC integrin in prostatic adenocarcinoma. J Cirn Invest 103:321-329, 1999
58. MAINIERO F, PEPE A, WARY KK, SPINARDI L, MOHAMMADI M, SCIILESSINGER J, GiANCOTTi FG: Signal transduction by the α6β4 integrin: Distinct β4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J 14:4470-4481, 1995
59. WARY KK, MAINIERO F, ISAKOFF SJ, MARCANTONIO EE, GIANCOTTI FG: The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell 87:733-743, 1996
60. WARY KK, MARIOTTI A, ZURZOLO C, GIANCOTTI FG: A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-634, 1998
61. PAWSON T, SCOTT JD: Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075-2080, 1997
62. MAINIERO F, MURGIA C, WARY KK, CURATOLA AM, PEPE A, BLUMEMBERG M, DER CI, WESTWTCK JK, GIANCOTTI FG: The coupling of a6β4 integrin to Ras-MAP kinase pathways mediated by She controls keratinocyte proliferation. EMBO J 16:2365-2375, 1997
63. KOYAMA H, RAINES EW, BORNFELDT KE, ROBERTS JM, Ross R: Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87:1069-1078, 1996
64. SCIIOECKLMANN HO, KRALEWSKi M, LANG S, SïERZEL RB: Distinct structural forms of type I collagen have different effects on proliferation of glomerular mesangial cells, (submitted for publication)
65. MIRALEM T, TEMPLETON DM: Inactivation of kinase cascades in mesangial cells grown on collagen type I. Am J Physiol 275:F585F594, 1998